Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinine Sulfate for COVID-19 in Hospitalized Adults
NCT05808231Unknown
- Sponsor
- Universitas Padjadjaran
- Start
- Apr 2021
- Primary completion
- Jun 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of quinine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Universitas Padjadjaran. Primary endpoint: Clinical condition assessed on a 7-point ordinal scale up to 10 days. Status: unknown.
02
Drugs
quinine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05808231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808231.